Be the first to know

Never miss an update from Mesoblast. Did you know that during reporting season, the announcements from ASX:MSB often move the market?

Mesoblast (ASX:MSB) Company Logo

By joining StockLight, you agree to our Terms & Conditions and Privacy Policy

Mesoblast (MSB)

AU ASX:MSB (1.9B)

3.19
-0.06 (-1.85%)
0:15am AEDT
LOADING
Loading price chart..

Summary

Current Price: $3.19
52w High/Low: $1.02 - 5.7
Market Cap: 1.9B
Price/Earnings: -
Dividend Yield: -
Volume/Average: 4.1M - 2.3M
Mesoblast (ASX:MSB) Company Logo

Listed in 2004

A biotechnology company in the area of adult stem cell technology.
Mesoblast (ASX:MSB) Company Logo

A biotechnology company in the area of adult stem cell technology.

Annual Reports

Annual Report to shareholders Oct 29th 2019
2019
(5.4mb)
Annual Report to shareholders Oct 30th 2018
2018
(2.5mb)
Annual Report to shareholders Oct 16th 2017
2017
(3.0mb)
Annual Report to shareholders Oct 21st 2016
2016
(6.3mb)
Preliminary Final Report (Including Appendix 4E) Aug 24th 2016
2016
(5.9mb)
Annual Report to shareholders Sep 21st 2015
2015
(3.9mb)

Dividend History

No dividends found.

Quantitative Ratios

Stock Ratios Locked
You viewed 3 companies today
Ratios will be unlocked
again tomorrow or;

Unlock these ratios,
configure alerts
and much more...

Download StockLight

All Ratios, Alerts and other features are available in our iOS and Android apps:
Download on iOS Download on Android

We are working on updating this web app to fully enable Quantitative Ratios. All other current web features including annual reports, price sensitive announcements, dividends and earnings transcripts are free to use here on our web app.
Dividend Yield
1.6%
 
0.0%
 
 
Industry Avg
MSB

UNATTRACTIVE: Mesoblast's dividend yield of 0.0% is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Implied Growth
26.0%
 
14.6%
 
 
Industry Avg
MSB

ATTRACTIVE: Mesoblast exhibits an implied growth ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. MSB calculation: 10% - (-$0.15 / $3.19) = 14.7% more
Price / Book
6.4
 
2.6
 
 
Industry Avg
MSB

ATTRACTIVE: Mesoblast exhibits a price/book ratio which is less than the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more
Price / Sales
23.6
 
39.7
 
 
Industry Avg
MSB

UNATTRACTIVE: Mesoblast exhibits a price/sales ratio which exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. more

Company News

Why CIMIC, Megaport, Mesoblast, & Temple & Webster shares are dropping lower
October 21st, 2020 - Motley Fool

CIMIC Group Ltd (ASX: CIM) The CIMIC share price is down 2% to $22.04. Investors have been selling the engineering company's shares after it advised that it will write-off a further $1 billion after losing a court battle with Chevron. This relat...

CSL (ASX:CSL) share price edges lower on annual R&D update
October 19th, 2020 - Motley Fool

What was in the update? This morning CSL released a comprehensive update on all its R&D activities. This includes its work across a number of programs to prevent and treat COVID-19 such as UQ/CSL V451 and AZD1222. UQ/CSL V451 is a recombinant ...

What happened to the Mesoblast Limited (ASX:MSB) share price?
October 18th, 2020 - Motley Fool

Where to from here? I have to admit to being quite bullish on Mesoblast, so it's disappointing that they haven't come away from their meeting with the FDA with a better outcome, particularly after ODAC voted so resoundingly in their favour. Howeve...

Got a spare $10,000 to invest? Smart investors should buy these ASX shares
October 18th, 2020 - Motley Fool

Appen Ltd (ASX: APX) I think this global leader in the development of high-quality, human annotated datasets for machine learning and artificial intelligence (AI) could be a great option for a $10,000 investment. In a presentation last year, man...

ASX 200 Weekly Wrap: Promises of easy money push ASX 200 to post-crash high
October 18th, 2020 - Motley Fool

RBA flags QE On Thursday, Reserve Bank of Australia (RBA) Governor, Dr. Philip Lowe, told Australians that the RBA is now ‘considering’ further easing, which may include the purchase of longer-term bonds (such as 5 or 10-year bonds). Until now, th...

3 ASX shares to hold forever
October 18th, 2020 - Motley Fool

Xero Limited (ASX: XRO) Xero is a leading cloud accounting software business. It has only been around for a decade and a half but it has already made massive market share gains in New Zealand and Australia. It's also growing really impressively ...

These are the 10 most shorted shares on the ASX
October 18th, 2020 - Motley Fool

Every Monday I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a s...

Short-sellers are stepping up their attack on these ASX stocks
October 13th, 2020 - Motley Fool

Short-sellers invading this Galaxy The stock that has seen the biggest increase in short bets over the past month is the Galaxy Resources Limited (ASX: GXY) share price. The latest ASIC data to 7 October (the data is always a week behind) showed 2...